Subscribe to RSS
![](/products/assets/desktop/img/oa-logo.png)
DOI: 10.1055/s-0044-1795153
Neuroprotective Role of Ranolazine: ESR1 and NMDA Receptor Agonist in Traumatic Brain Injury in Drosophila melanogaster, In Silico and In Vivo Correlation
Funding None.![](https://www.thieme-connect.de/media/10.1055-s-00029202/EFirst/lookinside/thumbnails/10-1055-s-0044-1795153_2490002-1.jpg)
Abstract
Objective In this study, a high-impact trauma (HIT) device was used for inducing moderate traumatic brain injury (TBI) in Drosophila melanogaster. Mechanical injuries in flies caused by rapid acceleration and assertion produce symptoms characteristics of TBI in humans.
Materials and Methods Docking studies were carried out to check the binding affinity of the drug toward the receptors. Various oxidative stress parameters, catalase level, glutathione level, superoxide dismutase (SOD) level, malondialdehyde (MDA), and nitric oxide levels, were measured. The mortality index and neuroprotective potential were carried out in TBI in D. melanogaster models.
Results In the current study, there was an increase in oxidative stress following TBI as evidenced by a significant decrease in the catalase, glutathione, and SOD levels and increase in the level of MDA and nitric oxide after 24 hours. Antioxidant enzymes, catalase and glutathione peroxidase, have a dominant role in TBI. Docking studies were carried out on estrogen receptor 1 (pdb: 1TVO and 1UOM) and NDMA receptor (pdb: 3QEL) as agonist showing the binding affinity of the drug toward the receptors. In comparison to the vehicle-treated group, there was a dose-dependent significant increase in the SOD level and percentage climbing along with a decrease in the MDA level and total protein content. The mortality index was also observed at three concentrations of ranolazine (1, 2, and 4 mg/mL) in D. melanogaster homogenate. These findings suggest that ranolazine has a good neuroprotective potential in the treatment of TBI in the D. melanogaster model.
Conclusion Present study concluded the scientific evaluation of neuroprotective potential of ranolazine in the treatment of TBI in the D. melanogaster model.
Publication History
Article published online:
25 November 2024
© 2024. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/)
Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India
-
References
- 1 Gururaj G. Epidemiology of traumatic brain injuries: Indian scenario. Neurol Res 2002; 24 (01) 24-28
- 2 Demlie TA, Alemu MT, Messelu MA, Wagnew F, Mekonen EG. Incidence and predictors of mortality among traumatic brain injury patients admitted to Amhara Region Comprehensive Specialized Hospitals, northwest Ethiopia, 2022. BMC Emerg Med 2023; 23 (01) 55
- 3 Abio A, Bovet P, Valentin B. et al. Changes in mortality related to traumatic brain injuries in the Seychelles from 1989 to 2018. Front Neurol 2021; 12 (12) 720434
- 4 Ray SK, Dixon CE, Banik NL. Molecular mechanisms in the pathogenesis of traumatic brain injury. Histol Histopathol 2002; 17 (04) 1137-1152
- 5 Gaetz M. The neurophysiology of brain injury. Clin Neurophysiol 2004; 115 (01) 4-18
- 6 Brett BL, Gardner RC, Godbout J, Dams-O'Connor K, Keene CD. Traumatic brain injury and risk of neurodegenerative disorder. Biol Psychiatry 2022; 91 (05) 498-507
- 7 Hasenfuss G, Maier LS. Mechanism of action of the new anti-ischemia drug ranolazine. Clin Res Cardiol 2008; 97 (04) 222-226
- 8 Kahlig KM, Hirakawa R, Liu L, George Jr AL, Belardinelli L, Rajamani S. Ranolazine reduces neuronal excitability by interacting with inactivated states of brain sodium channels. Mol Pharmacol 2014; 85 (01) 162-174
- 9 Kumar S, Singh G. Pharmacological potential of zonisamide and Nigella sativa per se and combination in high-impact trauma device-induced traumatic brain injury in Drosophila melanogaster . Fundam Clin Pharmacol 2023; 37 (03) 577-588
- 10 Xiu M, Wang Y, Yang D. et al. Using Drosophila melanogaster as a suitable platform for drug discovery from natural products in inflammatory bowel disease. Front Pharmacol 2022; 13: 1072715
- 11 Sanuki R. Drosophila models of traumatic brain injury. Front Biosci (Landmark Ed) 2020; 25 (01) 168-178
- 12 Kahsai L, Zars T. Learning and memory in Drosophila: behavior, genetics, and neural systems. Int Rev Neurobiol 2011; 99: 139-167
- 13 Mayer ML, Westbrook GL, Guthrie PB. Voltage-dependent block by Mg2+ of NMDA responses in spinal cord neurones. Nature 1984; 309 (5965): 261-263
- 14 Kleckner NW, Dingledine R. Requirement for glycine in activation of NMDA receptor expressed in Xenopus oocytes . Sciences (New York) 1988; 241: 853-857
- 15 Dong Q, Yang S, Liao H, He Q, Xiao J. Preclinical findings reveal the pharmacological targets of ferulic acid in the treatment of traumatic brain injury. Food Sci Nutr 2022; 10 (12) 4403-4410
- 16 Hooda T, Sharma S, Goyal N. Synthesis, in-silico, designing, microbiological evaluation and structure activity relationship of novel amide derivatives of 1-(2,4-dinitrophenyl)-2-(3-methylbenzo[b]thiophen-6-yl)-1H-benzo[d]imidazole-5-carboxylic acid. Polycycl Aromat Compd 2022; 42 (06) 3361-3376
- 17 Hooda T, Sharma S, Goyal N. In-silico designing, synthesis, SAR and microbiological evaluation of novel amide derivatives of 2-(3-methylbenzo[b]thiophen-6-yl)-1-(4-nitrophenyl)-1H-benzo[d]imidazole-5-carboxylic acid. IJPER 2019; 3 (02) 53
- 18 Hooda T, Sharma S, Goyal N. Synthesis, in-silico designing, SAR and microbiological evaluation of novel amide derivatives of 1-(4-nitrophenyl)-2-(3-methylbenzo[b] thiophen-6-yl)-1H-benzo[d]imidazole-5-carboxylic acid. IJPER 2020; 54 (02) 2020
- 19 Lather A, Sharma S, Khatkar A. Naringenin derivatives as glucosamine-6-phosphate synthase inhibitors: synthesis, antioxidants, antimicrobial, preservative efficacy, molecular docking and in silico ADMET analysis. BMC Chem 2020b; 14 (01) 41
- 20 Lather A, Sharma S, Khatkar S, Khatkar A. Docking related survey on heterocyclic compounds based on glucosamine-6- phosphate synthase inhibitors and their antimicrobial potential. Curr Pharm Des 2020a; 26 (15) 1650-1665
- 21 Katzenberger RJ, Loewen CA, Bockstruck RT, Woods MA, Ganetzky B, Wassarman DA. A method to inflict closed head traumatic brain injury in Drosophila . J Vis Exp 2015; 100 (100) e52905
- 22 Schlotterose L, Beldjilali-Labro M, Schneider G. et al. Traumatic brain injury in a well: a modular three-dimensional printed tool for inducing traumatic brain injury in vitro. Neurotrauma Rep 2023; 4 (01) 255-266
- 23 Zhao Q, Zhang J, Li H, Li H, Xie F. Models of traumatic brain injury-highlights and drawbacks. Front Neurol 2023; 14: 1151660
- 24 Behnke JA, Ye C, Setty A, Moberg KH, Zheng JQ. Repetitive mild head trauma induces activity mediated lifelong brain deficits in a novel Drosophila model. Sci Rep 2021; 11 (01) 9738
- 25 Buhlman LM, Krishna G, Jones TB, Thomas TC. Drosophila as a model to explore secondary injury cascades after traumatic brain injury. Biomed Pharmacother 2021; 142: 112079
- 26 Swanson LC, Trujillo EA, Thiede GH. et al. Survival following traumatic brain injury in Drosophila is increased by heterozygosity for a mutation of the NF-κB innate immune response transcription factor relish. Genetics 2020; 216 (04) 1117-1136
- 27 Bland ND, Robinson P, Thomas JE, Shirras AD, Turner AJ, Isaac RE. Locomotor and geotactic behavior of Drosophila melanogaster over-expressing neprilysin 2. Peptides 2009; 30 (03) 571-574
- 28 Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951; 193 (01) 265-275
- 29 Shukla S, Sharma S, Vasudeva N, Hooda T. Danshensu attenuates diabetes associated cognitive dysfunction by markedly reversingoxidative stress, Aβ and AChE activity. IJPER 2024; 58 (02) 503-509
- 30 Shukla S, Sharma S, Vasudeva N, Hooda T. Ameliorative effect of cichoric acid against diabetes associated cognitive decline with emphasison neurobehavioral activity, Aβ and AChE. IJPER 2024; 58 (02) 595-602
- 31 Kono Y. Generation of superoxide radical during autoxidation of hydroxylamine and an assay for superoxide dismutase. Arch Biochem Biophys 1978; 186 (01) 189-195
- 32 Chandramohan G, Al-Numair KS, Paugalendi KV. Restoration of altered plasma erythrocyte and liver antioxidant levels by 3-hydroxymethyl xylitol in streptozotocin diabetic rats. IJIB 2009; 5: 176-181
- 33 Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979; 95 (02) 351-358
- 34 Gupta DK, Nicoloso FT, Schetinger MRC, Rossato LV, Pereira LB, Castro GY, Srivastava S, Tripathi RD. Antioxidant defense mechanism in hydroponically grown Zea mays seedlings under moderate lead stress. J Hazard Mater 2009; 172 (01) 479-484